Zobrazeno 1 - 10
of 2 404
pro vyhledávání: '"resolvin"'
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background One of the most common, but least studied, diabetic complication is diabetic bladder dysfunction. Current therapies include glucose control and symptom-based interventions. However, efficacy of these therapies is mixed and often h
Externí odkaz:
https://doaj.org/article/2dcae694afff4061aec71ecfe978ba5a
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Sepsis is a life-threatening syndrome of organ dysfunction, characterized by uncontrolled inflammatory response and immune dysregulation, often leading to multiple organ failure and even death. Specialized pro-resolving mediators (SPMs), which are ty
Externí odkaz:
https://doaj.org/article/04bb4e7d87484bc2bc6e83ef61d89368
Publikováno v:
Fundamental Research, Vol 4, Iss 3, Pp 575-588 (2024)
Induction of beige fat for thermogenesis is a potential therapy to improve homeostasis against obesity. β3-adrenoceptor (β3-AR), a type of G protein-coupled receptor (GPCR), is believed to mediate the thermogenesis of brown fat in mice. However, β
Externí odkaz:
https://doaj.org/article/b57f3a15013a4592b83a67c1f896a147
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Inflammation has become a critical pathological mechanism of Major Depressive Disorder (MDD). NLRP3 is a critical inflammatory pathway to maintain the immune balance. Recently, preclinical evidence showed that Resolvin D1 might po
Externí odkaz:
https://doaj.org/article/a8cb69101e1346a685bad5e2af365f1d
Publikováno v:
BMC Veterinary Research, Vol 20, Iss 1, Pp 1-11 (2024)
Abstract Background Resolvin D1 (RvD1), a specialized pro-resolving lipid mediator (SPM), is derived from docosahexaenoic acid (DHA). It plays a key role in actively resolving inflammatory responses, which further reduces small intestinal damage. How
Externí odkaz:
https://doaj.org/article/8c6c452768fc4edd9e4b1ef00bf0f542
Publikováno v:
Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)
Abstract Aims Bone cancer produces severe pain that is treated with opioids, but serious side effects limit opioid utilization. There is therefore a need to develop effective and safe non‐opioid alternatives. The lipid mediator, Resolvin D1 (RvD1),
Externí odkaz:
https://doaj.org/article/20826b38ba244904b817eaa151787986
Autor:
Mitsuhiro Yoneda, Hidetaka Ideguchi, Shin Nakamura, Zulema Arias, Mitsuaki Ono, Kazuhiro Omori, Tadashi Yamamoto, Shogo Takashiba
Publikováno v:
Heliyon, Vol 10, Iss 13, Pp e34206- (2024)
Introduction: Vital pulp therapy (VPT) is performed to preserve dental pulp. However, the biocompatibility of the existing materials is of concern. Therefore, novel materials that can induce pulp healing without adverse effects need to be developed.
Externí odkaz:
https://doaj.org/article/35e6192e63c34b75be933b9f62100fd9
Autor:
Chen R, Li J, Sheng Z, Zhou J, Wang Y, Zhao X, Li N, Liu W, Liu C, Zhou P, Chen Y, Yan S, Song L, Yan H, Zhao H
Publikováno v:
Journal of Inflammation Research, Vol Volume 16, Pp 6457-6467 (2023)
Runzhen Chen,1,2,* Jiannan Li,1,3,* Zhaoxue Sheng,4 Jinying Zhou,1,3 Ying Wang,1 Xiaoxiao Zhao,1,3 Nan Li,1 Weida Liu,5 Chen Liu,1,3 Peng Zhou,1,3 Yi Chen,1,3 Shaodi Yan,2 Li Song,1– 3 Hongbing Yan,2,3 Hanjun Zhao1,3 1Department of Cardiolo
Externí odkaz:
https://doaj.org/article/36f68467c84a4af99a768531b2bd9e71
Autor:
Bingyue Liu, Jin Zhang, Kexin Zhang, Mengyuan Li, Yang Jing, Shujun Gu, Hongzhan Ding, Yanyu Liang, Hui Zhou, Chen Dong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background Resolvin D2 (RvD2) has been reported to protect against the development of atherosclerosis in animal models. The objective of this study was to examine the prospective association between plasma RvD2 and the risk of atherosclerotic cardiov
Externí odkaz:
https://doaj.org/article/1d8e83440ecb447a90e6c4335a334427
Autor:
Wang M, Pan W, Wei C, Liu J, Zhang J, Yu J, Zhao M, Xu S, Ye J, Wang Z, Ye D, Feng Y, Xu Y, Wan J
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 17, Pp 3073-3083 (2023)
Menglong Wang,1– 3,* Wei Pan,1– 3,* Cheng Wei,1– 3,* Jianfang Liu,1– 3 Jishou Zhang,1– 3 Junping Yu,1– 3 Mengmeng Zhao,1– 3 Shuwan Xu,1– 3 Jing Ye,1– 3 Zhen Wang,1– 3 Di Ye,1– 3 Yongqi Feng,1– 3 Yao Xu,1– 3 Jun W
Externí odkaz:
https://doaj.org/article/3b44affdd3234fe89ee4ab55c1ebdc08